These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8862076)

  • 21. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
    J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer.
    Whisenant J; Venook A
    Oncology (Williston Park); 2004 May; 18(6):762-8; discussion 769-73. PubMed ID: 15214595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases.
    Onaitis M; Morse M; Hurwitz H; Cotton P; Tyler D; Clavien P; Clary B
    Ann Surg; 2003 Jun; 237(6):782-8; discussion 788-9. PubMed ID: 12796574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
    Walker BS; Billingsley KG; Sutton TL; Kolbeck KJ; Korngold EK; Nabavizadeh N; Dewey EN; Herzig DO; Lopez CD; Mayo SC
    J Surg Oncol; 2022 Sep; 126(3):513-522. PubMed ID: 35522249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
    Kusunoki M; Yanagi H; Noda M; Yoshikawa R; Yamamura T
    Cancer; 2000 Sep; 89(6):1228-35. PubMed ID: 11002217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.
    Martin JK; O'Connell MJ; Wieand HS; Fitzgibbons RJ; Mailliard JA; Rubin J; Nagorney DM; Tschetter LK; Krook JE
    Arch Surg; 1990 Aug; 125(8):1022-7. PubMed ID: 2143063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.
    ; Piedbois P; Buyse M; Kemeny N; Rougier P; Carlson R; Allen-Mersh T; O'Connell M; Chang A; Sondak V; Kemeny M; Levy E
    J Natl Cancer Inst; 1996 Mar; 88(5):252-8. PubMed ID: 8614003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
    J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrahepatic arterial infusion of chemotherapy: clinical results.
    Dizon DS; Kemeny NE
    Semin Oncol; 2002 Apr; 29(2):126-35. PubMed ID: 11951210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of locoregional chemotherapy in patients with liver metastases from colorectal primaries.
    Lorenz M; Heinrich S; Staib-Sebler E; Gog C; Vetter G; Petrowsky H; Müller HH
    Swiss Surg; 2000; 6(1):11-22. PubMed ID: 10709432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: an alternative to FUdR-based regimens?
    Cosimelli M; Mannella E; Anzá M; Civalleri D; Balletto N; Di Tora P; Durante F; Porcellana M; Cavaliere P; Anfossi A
    J Surg Oncol Suppl; 1991; 2():63-8. PubMed ID: 1832541
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
    Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
    Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer.
    Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS
    Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial access.
    Copur MS; Capadano M; Lynch J; Goertzen T; McCowan T; Brand R; Tempero M
    J Clin Oncol; 2001 May; 19(9):2404-12. PubMed ID: 11331319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
    Kemeny N; Conti JA; Cohen A; Campana P; Huang Y; Shi WJ; Botet J; Pulliam S; Bertino JR
    J Clin Oncol; 1994 Nov; 12(11):2288-95. PubMed ID: 7964942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
    J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK).
    Borner M; Laffer U; Ludwig C; Obrist R; Metzger U; Aeberhard P; Weber W; Castiglione M; Obrecht JP; Brunner K
    Ann Oncol; 1990; 1(3):227-8. PubMed ID: 2261369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.